Therapeutic Classification: central nervous system stimulants
Pharmacologic Classification: respiratory stimulants
REMS
Absorption: IV administration results in complete bioavailability; also absorbed after oral administration.
Distribution: Rapidly distributes to the brain; CSF levels in neonates are similar to plasma levels.
Half-Life: Infants >9 mo, Children, and Adults: 5 hr; Neonates: 34 days.
Contraindicated in:
Use Cautiously in:
CV: tachycardia
Derm: dry skin, rash, skin breakdown
Endo: hyperglycemia, hypoglycemia
GI: GI bleeding, feeding intolerance, gastritis, NECROTIZING ENTEROCOLITIS
GU: increased urine output
MS: muscle tremors, twitches
Neuro: insomnia, irritability, jitteriness, restlessness
Drug-drug:
Lab Test Considerations:
Toxicity and Overdose:
IV Administration: